正丹股份(300641.SZ):目前公司已分離出偏三甲苯、甲乙苯,分別用於生產偏苯三酸酐、乙烯基甲苯
格隆匯5月6日丨正丹股份(300641.SZ)接受特定對象調研時表示,C9芳烴主要指催化重整副產的含九個碳原子的芳烴餾分,主要組分有偏三甲苯、甲乙苯、異丙苯、正丙苯、均三甲苯、連三甲苯、均四甲苯、茚等。目前公司已分離出偏三甲苯、甲乙苯,分別用於生產偏苯三酸酐、乙烯基甲苯;分離異丙苯用於生產α-甲基苯乙烯的項目正在建設中;分離均三甲苯用於生產均苯三甲酸已在研發中。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.